NO174100C - Analogifremgangsmåte for fremstilling av terapeutisk aktive piperidinylforbindelser - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive piperidinylforbindelser

Info

Publication number
NO174100C
NO174100C NO892870A NO892870A NO174100C NO 174100 C NO174100 C NO 174100C NO 892870 A NO892870 A NO 892870A NO 892870 A NO892870 A NO 892870A NO 174100 C NO174100 C NO 174100C
Authority
NO
Norway
Prior art keywords
group
denotes
optionally substituted
hydrogen atom
preparation
Prior art date
Application number
NO892870A
Other languages
English (en)
Norwegian (no)
Other versions
NO892870D0 (no
NO892870L (no
NO174100B (no
Inventor
Jonathan Frost
Patrick Lardenois
Jean Bertin
Alfred Saarmets
Corinne Rousselle
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8809449A external-priority patent/FR2634206B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO892870D0 publication Critical patent/NO892870D0/no
Publication of NO892870L publication Critical patent/NO892870L/no
Publication of NO174100B publication Critical patent/NO174100B/no
Publication of NO174100C publication Critical patent/NO174100C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO892870A 1988-07-12 1989-07-11 Analogifremgangsmåte for fremstilling av terapeutisk aktive piperidinylforbindelser NO174100C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8809449A FR2634206B1 (fr) 1988-07-12 1988-07-12 Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2 et quinoleinones-2, leur preparation et leur application en therapeutique
FR888816373A FR2640266B2 (fr) 1988-07-12 1988-12-13 Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique

Publications (4)

Publication Number Publication Date
NO892870D0 NO892870D0 (no) 1989-07-11
NO892870L NO892870L (no) 1990-01-15
NO174100B NO174100B (no) 1993-12-06
NO174100C true NO174100C (no) 1994-03-16

Family

ID=26226791

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892870A NO174100C (no) 1988-07-12 1989-07-11 Analogifremgangsmåte for fremstilling av terapeutisk aktive piperidinylforbindelser

Country Status (18)

Country Link
US (1) US5034401A (es)
EP (1) EP0351282B1 (es)
JP (1) JPH0272173A (es)
KR (1) KR900001684A (es)
AT (1) ATE96437T1 (es)
AU (1) AU618378B2 (es)
CA (1) CA1317292C (es)
DE (1) DE68910210T2 (es)
DK (1) DK341989A (es)
ES (1) ES2062064T3 (es)
FI (1) FI93012C (es)
FR (1) FR2640266B2 (es)
HU (1) HU201544B (es)
IE (1) IE62216B1 (es)
IL (1) IL90908A0 (es)
NO (1) NO174100C (es)
NZ (1) NZ229903A (es)
PT (1) PT91126B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182278A (en) * 1989-02-28 1993-01-26 Adir Et Compagnie Analgesic benzoxazolinones having at the 6-position a 1-hydroxy-3-morpholinopropyl side chain
CA2023492A1 (en) * 1989-08-31 1991-03-01 Barry Clifford Lange Herbicidal glutarimides
EP0554247B1 (en) * 1990-05-10 2000-04-26 Pfizer Inc. Neuroprotective indolone and related derivatives
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
FR2668149B1 (fr) * 1990-10-18 1994-09-23 Synthelabo Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.
TW197435B (es) * 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
FR2678270B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
EP0524846A1 (fr) * 1991-06-27 1993-01-27 Synthelabo Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique
AU655840B2 (en) * 1991-07-17 1995-01-12 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
TW263504B (es) * 1991-10-03 1995-11-21 Pfizer
FR2684379B1 (fr) * 1991-12-02 1995-04-28 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.
TW218875B (es) * 1992-03-09 1994-01-11 Takeda Pharm Industry Co Ltd
US5462934A (en) * 1992-03-09 1995-10-31 Takeda Chemical Industries Condensed heterocyclic ketone derivatives and their use
FR2688504B1 (fr) * 1992-03-13 1995-05-05 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
US6255322B1 (en) 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
PL173618B1 (pl) * 1992-10-30 1998-04-30 Pfizer Związki 6-[2-(4-hydroksy-4-fenylopiperydyno)-1-hydroksypropylo]-3,4-dihydro-2(1H)-chinolonowe
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
BR9408506A (pt) * 1994-01-31 1997-08-05 Pfizer Compostos neuroprotetores
ATE174915T1 (de) * 1994-10-31 1999-01-15 Merck Patent Gmbh Benzylpiperidinderivate mit hoher affinität zu bindungsstellen von aminosäure-rezeptoren
FR2738568B1 (fr) * 1995-09-08 1997-10-17 Synthelabo Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique
TR199800407T1 (xx) * 1995-09-08 1998-05-21 Synthelabo 4-(Sikloalkil) piperidin ve t�revleri, haz�rlan��lar�, tedavi ama�l� kullan�mlar�.
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
EP1034174B1 (en) * 1997-11-05 2003-08-13 Neurosearch A/S Azaring-ether derivatives and their use as nicotinic ach receptor modulators
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
NZ604423A (en) * 2010-06-24 2015-01-30 Alkermes Pharma Ireland Ltd Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3217011A (en) * 1965-05-07 1965-11-09 Sterling Drug Inc 1-(indolyglyoxalyl)-piperidines
JPS51125291A (en) * 1974-12-07 1976-11-01 Otsuka Pharmaceut Co Ltd A process for preparing novel carbostyryl derivatives
JPS51118772A (en) * 1975-04-09 1976-10-18 Otsuka Pharmaceut Co Ltd Method for preparing carbostyryl derivatives
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2528043A1 (fr) * 1982-06-03 1983-12-09 Roussel Uclaf Nouveaux derives de la 1,3-dihydro 4-/1-hydroxy-2-amino-ethyl/2h-indol-2-one, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
US4788201A (en) * 1987-01-22 1988-11-29 Hoechst-Roussel Pharmaceuticals Inc. 3-methylenespiro (benzofuranpiperidines)

Also Published As

Publication number Publication date
US5034401A (en) 1991-07-23
NO892870D0 (no) 1989-07-11
EP0351282B1 (fr) 1993-10-27
IE892237L (en) 1990-01-12
PT91126A (pt) 1990-02-08
DK341989D0 (da) 1989-07-11
DK341989A (da) 1990-04-25
NO892870L (no) 1990-01-15
AU3802989A (en) 1990-01-18
ATE96437T1 (de) 1993-11-15
FI893365A7 (fi) 1990-01-13
DE68910210D1 (de) 1993-12-02
JPH0272173A (ja) 1990-03-12
AU618378B2 (en) 1991-12-19
PT91126B (pt) 1994-12-30
HU201544B (en) 1990-11-28
DE68910210T2 (de) 1994-05-11
HUT50328A (en) 1990-01-29
NO174100B (no) 1993-12-06
EP0351282A1 (fr) 1990-01-17
CA1317292C (en) 1993-05-04
IE62216B1 (en) 1995-01-11
KR900001684A (ko) 1990-02-27
FI93012C (fi) 1995-02-10
IL90908A0 (en) 1990-02-09
FI93012B (fi) 1994-10-31
FR2640266A2 (fr) 1990-06-15
NZ229903A (en) 1991-04-26
FR2640266B2 (fr) 1992-07-10
ES2062064T3 (es) 1994-12-16
FI893365A0 (fi) 1989-07-11

Similar Documents

Publication Publication Date Title
NO892870D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NL180206C (nl) Verbinding en geneesmiddel met analgetische werking.
SE8406200L (sv) Indolderivat
ATE150021T1 (de) 2-piperidino-1-alkanol-derivate als antiischemische wirkstoffe
YU32196A (sh) Upotreba jedinjenja za pripremanje leka korisnog za inhibiranje migracije vaskularnih ćelija glatkog mišića
DE3866646D1 (de) 1-((2-pyrimidinyl)-aminoalkyl)-piperidine, deren herstellung und verwendung als heilmittel.
DE3852107D1 (de) Bestimmte 3-substituierte 2-alkyl-benzofuran-derivate.
FI913565A0 (fi) Substituerade fenylacetylenfoereningar, laekemedel innehaollande dem samt ett foerfarande foer framstaellning av dessa foereningar och laekemedel.
NO308002B1 (no) N-p-halogenbenzoylmetylderivater av 4-(p-fluorfenyl)-3-[[3,4- metylendioksy)fenoksy]metyl]piperidin, farmasøytisk preparat inneholdende slike derivater, og anvendelse derav
FI843155A0 (fi) Framstaellning av indolinderivat och deras terapeutiska tillaempning.
ATE139441T1 (de) Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe
KR900701770A (ko) 벤조 티아디아제핀 유도체
SE8302452D0 (sv) Method for treatment of senile dementia
FR2683221B1 (fr) Nouveaux derives de cinnolinones-4, leur preparation et leur application en therapeutique.
HU9401512D0 (en) 2-amino-pyrazine-5-carboxamide derivatives process for producing them and their therapeutic application
NO931602L (no) Nye enantiomerer avledet fra (s)-2-amino-2-(3,4-diklorbenzyl)-1-propanol
FR2457290A2 (fr) Nouveaux derives de 1,3 dihydro 3-/1-/2-(2,3-dihydro 1,4-benzodioxin-2-yl) 2-hydroxy-ethyl/piperidin-4-yl/2h-indol-2-one, procede pour leur preparation et application comme medicaments

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees